Biopharmaceutical company.
Monitored issues and legislation related to the 340(b) program. H.R.5801: HELP Copays Act. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX